Last Updated: 31-07-2025 | Format: PDF | Report ID:20410 | Author: Lily
| Key Market Question | Answer |
|---|---|
| What is the market size in 2025? | $1,250 Million |
| What is the projected market size by 2035? | $2,750 Million |
| What is the market CAGR from 2025 to 2035? | 8.2% |
| Which region dominates the market? | US (82%) |
| Which product/service type dominates the market? | Monoclonal Antibodies (39%) |
| Which application leads the market? | Research (46%) |
| Who are the major buyers? | Academic Institutes (54%), Pharma Companies (27%) |
| What are the key market growth drivers? | Rising investments in neurodegenerative disease research; The growing adoption of personalized medicine is increasing the use of biomarkers in neurological diagnostics |
| What are the major market challenges? | High development costs and stringent regulatory requirements can delay product launches and impact market entry; Batch-to-batch variability in polyclonal antibodies can limit reproducibility |
| What is the forecast period? | 2026–2035 |
Study period:
2020-2035
Base year:
2026
Historical data
2020-2024
NO OF PAGE:
167
What You Get:
| Who are the key market players? |
| Thermo Fisher Scientific Inc., Merck KGaA, Bio-Rad Laboratories, Inc., Abcam plc, Cell Signaling Technology, Inc., Rockland Immunochemicals, Inc., GenScript Biotech Corporation, Agilent Technologies, Inc., Novus Biologicals, LLC, Santa Cruz Biotechnology, Inc., PerkinElmer, Inc., Enzo Life Sciences, Inc., Lonza Group Ltd, BioLegend, Inc., MilliporeSigma |
Global Biosimilars Treatment Market: by Type (Monoclonal Antibodies, Recombinant Hormones, Fusion Proteins, Immunomodulators, Insulins, Erythropoietin), Application (Oncology, Autoimmune Diseases, Chronic Diseases, Blood Disorders, Infectious Diseases, Other Applications), Distribution Channels (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Specialty Clinics, Drug Stores, Others), Technology (Recombinant DNA Technology, Monoclonal Antibody Technology, Genomics, Proteomics, Bioengineering, Others), Organization Size (Small, Medium, Large) and By Global – Historical & Forecast Period (2020-2035) Comprehensive Study 2025
North America Newborn Screening Market: by Type (Blood Tests, Hearing Screening, Pulse Oximetry, Genetic Testing, Critical Congenital Heart Disease Screening, Other Types), Application (Dry Blood Spot Screening, Hearing Screening, Cystic Fibrosis, Sickle Cell Disease, Critical Congenital Heart Disease, Other Applications), Distribution Channels (Hospitals, Diagnostic Centers, Clinics, Laboratories, Specialty Centers, Other Distribution Channels), Technology (Tandem Mass Spectrometry, Immunoassays & Enzymatic Assays, Pulse Oximetry, Molecular Assays, Hearing Screening Technology, Other Technologies), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025
North America Hemato Oncology Testing Market: by Type (Assays and Kits, Services), Application (Leukemia, Lymphoma, Myeloma, Others), Distribution Channels (Direct Tenders, Retail Sales, Online Sales, Others), Technology (PCR, NGS, IHC, FISH, Cytogenetics, Other Technologies), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025
North America HLA Typing Market Market: by Type (Molecular Assays, Non-Molecular Assays), Application (Transplantation, Research, Disease Diagnosis, Donor Screening, Drug Discovery, Others), Distribution Channels (Direct Tenders, Retail Sales, Online Sales, Distributors & Wholesalers, Hospital Pharmacies, Others), Technology (PCR-Based Molecular Assays, Sequencing-Based Molecular Assays, SSO-PCR, SSP-PCR, Non-Molecular Assays, Other Technologies), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025
North America Metabolism Assays Market: by Type (Cell-based Assays, Biochemical Assays, Consumables, Instruments, Software, Others), Application (Drug Discovery & Development, Clinical Diagnostics, Toxicology, Disease Research, Biomarker Discovery, Others), Distribution Channels (Direct Sales, Distributors, Online, Retail, Institutional, Others), Technology (Fluorescence, Colorimetric, Luminescence, Spectrophotometry, Chromatography, Others), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025